eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry; Availability: Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Agents forTreatment

Draft Guidance for Industry; Availability: Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Agents forTreatment

Document ID: FDA-2010-D-0462-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2010-22806
View Document:  View as format pdf View as format html

Details Information

Document Subtype: NAD-Notice of Availability of Data
Received Date: September 13 2010, at 12:00 AM Eastern Daylight Time
Start-End Page: 55797 - 55798
Page Count: 2
Comment Start Date: September 14 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: November 15 2010, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 12
Merck & Co, Inc. - Comment
Posted: 11/18/2010     ID: FDA-2010-D-0462-0004

Nov 15,2010 11:59 PM ET
Novartis - Comment
Posted: 11/18/2010     ID: FDA-2010-D-0462-0006

Nov 15,2010 11:59 PM ET
GlaxoSmithKline - Comment
Posted: 11/18/2010     ID: FDA-2010-D-0462-0007

Nov 15,2010 11:59 PM ET
Merck & Company - Comment
Posted: 11/18/2010     ID: FDA-2010-D-0462-0008

Nov 15,2010 11:59 PM ET
Gilead Sciences Inc. - Comment
Posted: 11/18/2010     ID: FDA-2010-D-0462-0010

Nov 15,2010 11:59 PM ET

Related Documents

Total: 0
No documents available.